Koers True Leaf Medicine International Ltd Deutsche Boerse AG
Aandelen
CA89785C1077
Farmaceutische producten
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 4,2 mln. 3,08 mln. 2,84 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -6 mln. -4,4 mln. -4,05 mln. | Nettowinst (verlies) 2022 | -2 mln. -1,47 mln. -1,35 mln. | EV/omzet 2021 | - |
Nettoschuld 2021 | 4,22 mln. 3,09 mln. 2,85 mln. | Nettoschuld 2022 | 5,91 mln. 4,33 mln. 3,99 mln. | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-1,36
x | K/w-verhouding 2022 |
-1,66
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 88,37% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Darcy E. Bomford
FOU | Founder | - | 01-01-13 |
Jennifer Pace
DFI | Director of Finance/CFO | - | 01-04-20 |
Rik Klingle-Watt
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mike Harcourt
CHM | Chairman | - | 09-06-14 |
Jennifer Pace
DFI | Director of Finance/CFO | - | 01-04-20 |
Darcy E. Bomford
FOU | Founder | - | 01-01-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+41,06% | 6,26 mld. | |
-15,95% | 4,49 mld. | |
+6,36% | 3,29 mld. | |
-11,34% | 3,12 mld. | |
-3,12% | 2,5 mld. | |
+45,41% | 1,94 mld. | |
-7,74% | 1,68 mld. | |
-0,67% | 1,63 mld. | |
-11,32% | 1,56 mld. |